Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

New ABPI chief executive to focus on industry reputation

September 8, 2011 Research and Development, Sales and Marketing ABPI, industry relations

The new chief executive of the ABPI used his first public speech to focus on the reputation of the pharma …
News

Algeta appoints first head of comms and investor relations

September 8, 2011 Medical Communications, Research and Development appointment, medical communications, research and development

Norwegian biotech Algeta has appointed Dr Mike Booth to the newly-created role of senior VP of communications and corporate affairs. …
Appointment

Clinical research news in brief

September 8, 2011 Research and Development research and development news

This roundup includes using social media to recruit trial subjects, a strategic level service deal between BMS and Icon, plus …
News

Eisai shares risk with novel trial funding approach

September 7, 2011 Research and Development Eisai, clinical trials, research and development news

Eisai has unveiled a novel risk-sharing approach to accelerate its late-stage research programme by accepting new sources of clinical trial …
News
EMA

EMA should compare ‘like-for-like’ when assessing new drugs

September 7, 2011 Research and Development EMA, clnical trials, research and development news

The European system of comparing drugs against placebo and not against a comparator is flawed, according to a new LSE …
News

Lilly considering a stake in Turkish drugmaker

September 6, 2011 Manufacturing and Production, Research and Development, Sales and Marketing MN Pharmaceuticals, Turkey, lilly, research and development news

Eli Lilly is reportedly eyeing up a partnership with Turkish drugmaker Mustafa Nevzat Ilac Sanayi (MN Pharmaceuticals) in order to …
News

Zonegran study could pave way for paediatric licence

September 2, 2011 Research and Development, Sales and Marketing Eisai, Zonegran, epilepsy, research and development news

Eisai’s epilepsy drug Zonegran has been found more effective than placebo in children with the neurological condition who have seizures. …
News
Pfizer Sandwich Kent

Ex-Pfizer employees set up new business at Sandwich

September 1, 2011 Research and Development Pfizer, Sandwich, The Research Network, research and development news

Seven former Pfizer employees have set up a new business in Sandwich that will provide outsourcing services for the pharma …
News

Stem cell trial for stroke is safe

September 1, 2011 Research and Development ReNeuron, Stem cells, stroke

A pioneering stem cell treatment for patients who have suffered a stroke has been ruled safe, and can continue to …
News

Merck acquires cell imaging instrument maker Amnis

September 1, 2011 Research and Development Merck KGaA, Millipore

EMD Millipore, the Massachussetts-based life sciences arm of Merck KGaA, has bought US cell imaging instrument maker Amnis Corporation for …
News

Boehringer expands afatinib breast cancer trials

August 31, 2011 Research and Development Boehringer, afatinib

Boehringer Ingelheim has begun two new phase II trials of its investigational cancer drug afatinib. The studies will cover afatinib’s …
News

New electronic submission validation criteria

August 29, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

On Thursday 1st September a new version of the validation criteria for electronic submissions for human medicines will come into …
News
Press release

Clinical research news in brief

August 24, 2011 Research and Development contract research news, research and development news

Private equity firm the Carlyle Group is rumoured to be looking at buying PPD, plus there are updates from CTA/Clininvent, …
News
quintiles_consulting_troy_norris

Quintiles appoints Troy Norris to head up consulting group

August 24, 2011 Research and Development appointment, research and development

Troy Norris has joined Quintiles as vice president and managing director for the product development and commercialisation practice at its …
Appointment

UK research receives £800m funding boost

August 23, 2011 Research and Development NIHR, UK research, UK science, research and development news

Research into dementia, cancer, diabetes and heart disease are among the activities to benefit from a new £800 government funding …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026